Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026)
Phibro Animal Health (PAHC) posted Retained Earnings of $353.0 million for Q2 2026, up 5.01% on a QoQ basis from $336.1 million in Q1 2026, and up 29.43% year-over-year from $272.7 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Retained Earnings for 14 years, with the latest figure at $353.0 million in Q2 2026.
- On a quarterly basis, Retained Earnings rose 29.43% year-over-year to $353.0 million in Q2 2026; TTM through Jun 2026 was $353.0 million, a 29.43% increase from a year earlier, with the FY2026 full-year figure at $353.0 million, up 29.43% from the prior year.
- Retained Earnings was $353.0 million for Q2 2026 at Phibro Animal Health, up from $336.1 million in the prior quarter.
- The five-year high for Retained Earnings was $353.0 million in Q2 2026, with the low at $243.9 million in Q2 2024.
- Average Retained Earnings over 5 years is $267.3 million, with a median of $248.6 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings decreased 6.53% in 2024, then climbed 29.73% in 2025.
- Over 5 years, Retained Earnings stood at $249.1 million in 2022, then dropped by 1.86% to $244.4 million in 2023, then declined by 0.05% to $244.3 million in 2024, then gained by 29.73% to $317.0 million in 2025, then gained by 11.36% to $353.0 million in 2026.
- The last three Retained Earnings figures came in at $353.0 million (Q2 2026), $336.1 million (Q1 2026), and $317.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 7.01 Bn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 14.65 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 8.88 Bn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 352.96 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | -11.43 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | -3.05 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 2.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 352.96 Mn |
| Mar 31, 2026 | 336.12 Mn |
| Dec 31, 2025 | 316.96 Mn |
| Sep 30, 2025 | 294.36 Mn |
| Jun 30, 2025 | 272.70 Mn |
| Mar 31, 2025 | 260.34 Mn |
| Dec 31, 2024 | 244.33 Mn |
| Sep 30, 2024 | 246.00 Mn |
| Jun 30, 2024 | 243.89 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | 244.45 Mn |
| Sep 30, 2023 | 248.04 Mn |
| Jun 30, 2023 | 260.91 Mn |
| Mar 31, 2023 | 254.28 Mn |
| Dec 31, 2022 | 249.09 Mn |
| Sep 30, 2022 | 246.74 Mn |
| Jun 30, 2022 | 247.75 Mn |
| Mar 31, 2022 | 245.12 Mn |
| Dec 31, 2021 | 232.29 Mn |
| Sep 30, 2021 | 219.69 Mn |